These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32785967)

  • 21. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
    Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
    Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
    Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
    PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of microRNA-92b-3p suppresses proliferation, migration, and invasion of gastric cancer SGC-7901 cells by targeting Homeobox D10.
    Li C; Huo B; Wang Y; Cheng C
    J Cell Biochem; 2019 Oct; 120(10):17405-17412. PubMed ID: 31106881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
    Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of miR-148a in gastric cancer.
    Xia J; Guo X; Yan J; Deng K
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1451-6. PubMed ID: 24659367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-148a-3p overexpression contributes to glomerular cell proliferation by targeting PTEN in lupus nephritis.
    Qingjuan L; Xiaojuan F; Wei Z; Chao W; Pengpeng K; Hongbo L; Sanbing Z; Jun H; Min Y; Shuxia L
    Am J Physiol Cell Physiol; 2016 Mar; 310(6):C470-8. PubMed ID: 26791485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
    Zhang C; Zou Y; Dai DQ
    Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-371a-3p promotes progression of gastric cancer by targeting TOB1.
    Guo H; Ji F; Zhao X; Yang X; He J; Huang L; Zhang Y
    Cancer Lett; 2019 Feb; 443():179-188. PubMed ID: 30529155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
    Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
    Chen Y; Wu N; Liu L; Dong H; Liu X
    J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-222-3p associated with Helicobacter pylori targets HIPK2 to promote cell proliferation, invasion, and inhibits apoptosis in gastric cancer.
    Tan X; Tang H; Bi J; Li N; Jia Y
    J Cell Biochem; 2018 Jul; 119(7):5153-5162. PubMed ID: 29227536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
    Tang Y; Yang P; Zhu Y; Su Y
    Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of miR-148a on the proliferation of gastric carcinoma MKN45 cells and its mechanism].
    Qiu G; Wang S; Li D; Li J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):1036-9. PubMed ID: 25341915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.
    Zhao Z; Wang L; Song W; Cui H; Chen G; Qiao F; Hu J; Zhou R; Fan H
    World J Surg Oncol; 2015 Mar; 13():101. PubMed ID: 25889078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
    Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
    J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA-148a-3p inhibited the proliferation and epithelial-mesenchymal transition progression of non-small-cell lung cancer via modulating Ras/MAPK/Erk signaling.
    Xie Q; Yu Z; Lu Y; Fan J; Ni Y; Ma L
    J Cell Physiol; 2019 Aug; 234(8):12786-12799. PubMed ID: 30536836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.
    Kong P; Zhu X; Geng Q; Xia L; Sun X; Chen Y; Li W; Zhou Z; Zhan Y; Xu D
    Mol Ther; 2017 Apr; 25(4):1027-1037. PubMed ID: 28254439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-148a downregulates the expression of transforming growth factor-β2 and SMAD2 in gastric cancer.
    Zhang W; Li Y
    Int J Oncol; 2016 May; 48(5):1877-85. PubMed ID: 26983401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway.
    Takao K; Konishi H; Matsubara D; Shoda K; Arita T; Shimizu H; Komatsu S; Shiozaki A; Yamamoto Y; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Anticancer Res; 2021 May; 41(5):2441-2449. PubMed ID: 33952469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.